NeuroSense Therapeutics Stock (NASDAQ: NRSN)
|Day Range1.63 - 1.69||52 Wk Range1.23 - 8.18||Open / Close1.63 / 1.64||Float / Outstanding5.7M / 11.7M|
|Vol / Avg.14.8K / 3.7M||Mkt Cap19.1M||P/E-||50d Avg. Price1.97|
|Div / Yield-||Payout Ratio-||Total Float5.7M||EPS-0.31|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of NeuroSense Therapeutics (NASDAQ: NRSN) through any online brokerage.
There are no as such competitors for NeuroSense Therapeutics.
The latest price target for NeuroSense Therapeutics (NASDAQ: NRSN) was reported by Maxim Group on Friday, January 7, 2022. The analyst firm set a price target for 7.00 expecting NRSN to rise to within 12 months (a possible 326.83% upside). 1 analyst firms have reported ratings in the last year.
The stock price for NeuroSense Therapeutics (NASDAQ: NRSN) is $1.64 last updated Today at September 26, 2022, 8:00 PM UTC.
There are no upcoming dividends for NeuroSense Therapeutics.
NeuroSense Therapeutics’s Q3 earnings are confirmed for Tuesday, November 15, 2022.
There is no upcoming split for NeuroSense Therapeutics.
NeuroSense Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.